AC Immune SA Total Revenue

The latest total revenue for ACIU is $17M as of June 2026. That compares with $29M in the prior-year period — down 40.0% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside AC Immune SA's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACIU's total revenue moved from $29M to $17M — a 40.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AC Immune SA's operating scale or balance-sheet position.

Against Healthcare companies, ACIU currently prints $17M for total revenue, while the sector average sits near $110B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at AC Immune SA's growth, margins, and balance sheet.

A total revenue figure of $17M for ACIU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting ACIU's total revenue ($17M), review year-over-year change from $29M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.